Geron Corporation Reports Second Quarter 2017 Financial Results
August 09, 2017 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2017. For the second quarter of...
Geron Announces Updates to Imetelstat Clinical Development
July 31, 2017 19:00 ET
|
Geron Corporation
MENLO PARK, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced updates to the clinical development plans for IMerge and IMbark, the ongoing trials of the...
Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events
May 09, 2017 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter...
Geron 2017 Annual Meeting of Stockholders to be Held on May 9
April 25, 2017 07:30 ET
|
Geron Corporation
First Quarter 2017 Financial Results Expected Same Day MENLO PARK, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2017 Annual Meeting of Stockholders, on...
Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen
April 10, 2017 07:30 ET
|
Geron Corporation
Both IMerge and IMbark Continue in Lower Risk Myelodysplastic Syndromes and Relapsed or Refractory Myelofibrosis Conference Call Scheduled for 8:00 a.m. EDT Today, April 10 MENLO PARK, Calif.,...
Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time
April 09, 2017 08:00 ET
|
Geron Corporation
MENLO PARK, Calif., April 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on April 10, 2017, at 8:00 a.m. Eastern Time to provide an update on the ongoing...
Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting
April 05, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., April 05, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced a poster presentation by Janssen Research & Development, LLC describing non-clinical data...
Geron Announces Presentation at American Association for Cancer Research Annual Meeting
March 02, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data...
Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
March 01, 2017 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2016 and recent events. ...
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results
February 22, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March...